QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAseq xHYB Mycobacterium tuberculosis Panel for research use, a new tool in the fight against tuberculosis (TB), the world’s leading infectious disease killer.

Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test
Immunovia (NASDAQ Stockholm: IMMNOV), the diagnostics company with the mission to increase pancreatic cancer survival through early detection, today announces its next-generation pancreatic cancer test achieved both the primary and secondary endpoints in a model-development study.

AIRS Medical Accelerates Global Expansion with MRI AI Solution SwiftMR™ Supply Contracts in Germany and the UK
AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, recently announced that it has signed supply contracts in Germany and the UK. Following these contracts, the company plans to expedite its overseas market penetration and solidify its presence in European markets.